Predictive Oncology Inc (NAS:POAI)
$ 0.75 -0.0861 (-10.3%) Market Cap: 5.00 Mil Enterprise Value: 2.94 Mil PE Ratio: 0 PB Ratio: 1.04 GF Score: 52/100

Q4 2023 Predictive Oncology Inc Earnings Call Transcript

Apr 01, 2024 / 12:30PM GMT
Release Date Price: $2.27 (-10.98%)
Operator

Greetings and welcome to the Predictive Oncology fourth quarter 2023 earnings call. At this time, all participants are in a listen only mode and a brief question and answer session will follow the formal presentation. (Operator Instructions) As a reminder, this conference is being recorded and is now my pleasure to introduce your host, Glenn Garmont of LifeSci Advisors. Thank you, Glenn. You may begin.

Glenn Garmont
LifeSci Venture Partners LP - IR

Welcome and thank you, everyone, for dialing into the Predictive Oncology full year 2023 financial results call. First, you'll hear from our Chief Executive Officer and Chairman of the Board, Raymond Vennare; then our Chief Financial Officer, Josh Blacher will review our financials.

Certain matters discussed on this call contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties and assumptions about our operations and the investments we make all statements other than statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot